Jeffrey S Rollo

A Randomized and Clinical Effectiveness Trial Comparing Two Pharmacogenetic Algorithms and Standard Care for Individualizing Warfarin Dosing (CoumaGen-II)

B. Horne, J. Carlquist, T. Bair, 2012, Circulation.

Utility of high density lipoprotein particle concentration in predicting future major adverse cardiovascular events among patients undergoing angiography.

H. May, Jeffrey L. Anderson, M. Connelly, 2016, Clinical biochemistry.

Incidence of Dementia in Relation to Genetic Variants at PITX2, ZFHX3, and ApoE ε4 in Atrial Fibrillation Patients

H. May, J. Carlquist, T. Bunch, 2015, Pacing and clinical electrophysiology : PACE.

Cardiovascular risk among patients on clopidogrel anti-platelet therapy after placement of drug-eluting stents is modified by genetic variants in both the CYP2C19 and ABCB1 genes

B. Horne, H. May, J. Carlquist, 2013, Thrombosis and Haemostasis.

GLYCA AND GLYCB, NOVEL NMR BIOMARKERS OF INFLAMMATION, STRONGLY PREDICT FUTURE CARDIOVASCULAR EVENTS, BUT NOT THE PRESENCE OF CORONARY ARTERY DISEASE (CAD), AMONG PATIENTS UNDERGOING CORONARY ANGIOGRAPHY: THE INTERMOUNTAIN HEART COLLABORATIVE STUDY

H. May, Jeffrey L. Anderson, M. Connelly, 2014 .